Pharmaceutical Nanomaterials and Nanotoxicology
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (31 October 2024) | Viewed by 464
Special Issue Editors
Interests: nanomaterial properties; reactivity; toxicity; solubility; bio-nano interactions
Special Issues, Collections and Topics in MDPI journals
Interests: nanomedicine; drug delivery; nanotoxicology; carbon-based nanomaterials; nanoparticles
Special Issues, Collections and Topics in MDPI journals
Interests: transformation of (nano)materials; metal organic frameworks; nano-bio interactions; nanomedicines; advanced in vitro models
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The field of pharmaceutical nanomaterials and nanotoxicology stands at the frontier of innovative research, bridging crucial gaps in medical and pharmaceutical applications through the development of novel nano-based platforms for diagnosis, treatment, and drug delivery. This area of study harnesses the unique properties of nanomaterials to create systems with enhanced selectivity, sensitivity, and performance over traditional approaches, potentially revolutionizing patient care by enabling the early detection of diseases, enhancing drug efficacy, and minimizing side effects.
Given the rapid expansion of nanotechnology into biomedical and pharmaceutical fields over the last two decades, the investigation of the safety and toxicity of nanomaterials has become a pivotal concern. Nanotoxicology, as an emerging discipline, evaluates the unintended hazardous effects of nanoparticles on human health and the environment, focusing on their interactions with biological components that may lead to adverse outcomes. This includes assessing cellular stress, cytotoxicity, and the broader implications of nanoformulations on pharmacokinetics and organ toxicity. The complexity of nanomaterial interactions necessitates the development of novel methods and approaches for the evaluation of safety, highlighting the criticality of understanding adverse outcome pathways (AOPs) and employing advanced molecular biology techniques for comprehensive risk assessment.
This Special Issue welcomes the submission of original research articles and reviews that contribute to the knowledge base in the field of pharmaceutical nanomaterials and nanotoxicology. We seek submissions that explore innovative nanomaterials for drug delivery systems, biosensors, gene and drug delivery, enzyme immobilization, and contrast agents for bio-imaging. Contributions may also focus on the application of nanotechnology in cancer diagnostics, treatment, and tissue engineering, as well as studies addressing the potential health and environmental risks associated with the biomedical and pharmaceutical application of nanomaterials. By compiling a collection of at least 10 articles, this Special Issue aims to foster a deeper understanding of the impact of nanomaterials on health and the environment, thus promoting the safe and effective application of nanotechnology in medicine and pharmacy.
We look forward to receiving your contributions.
Prof. Dr. Eugenia Valsami-Jones
Dr. Hanene Ali-Boucetta
Dr. Swaroop Chakraborty
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotoxicology
- nanomaterials for drug delivery
- synthesis, characterization, and toxicity of new nanomaterials
- nanoformulations
- environmental nanotoxicology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
